This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jevnikar, A. M. Articles by Kelley, V. R. Search for Related Content PubMed PubMed Citation Articles by Jevnikar, A. M. Articles by Kelley, V. R.

American Journal of Pathology, Vol 141, 743-751, Copyright © 1992 by American Society for Investigative Pathology

REGULAR ARTICLES

Dexamethasone prevents autoimmune nephritis and reduces renal expression of Ia but not costimulatory signals

AM Jevnikar, GG Singer, DC Brennan, HW Xu and VR Kelley
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.

Although glucocorticoids are a conventional treatment for lupus nephritis, the cellular and molecular mechanisms responsible for preventing renal injury are unknown. MRL-lpr mice develop an aggressive autoimmune nephritis. As these mice become nephritic, there is an increase in the renal expression of molecules that permit or facilitate immune interactions, including MHC class II (Ia) antigens, intercellular adhesion molecule-1 (ICAM-1), and pro-inflammatory cytokines. Because dexamethasone (Dex) alters Ia antigen expression and suppresses cytokine generation, the authors prophylactically treated MRL-lpr mice and investigated the relative importance of these molecules in inducing renal injury. MRL-lpr mice given Dex (0.4 mg/kg/d) from age 6 weeks were killed 4, 8, and 16 weeks after the initiation of therapy, and tissue was removed for histology and extraction of total RNA. Dex prevented lymphadenopathy and renal injury. DEX eliminated the marked Thy 1.2+ lymphocytic infiltrates within the kidney and preserved normal renal histology and urinary protein levels. Northern blot analysis of steady-state mRNA transcripts indicated Dex suppressed a four-fold increase in kidney major histo- compatibility complex class II (Ia) molecule antigen mRNA seen by age 22 weeks (Ia/beta-actin ratios = 0.64 +/- 0.50 versus 2.32 +/- 0.48, P less than 0.01), but did not alter the costimulatory molecules ICAM-1 or tumor necrosis factor alpha (TNF alpha). Although all of these molecules are important mediators of inflammation, autoimmune nephritis was ameliorated without alteration of TNF alpha gene transcription or ICAM-1 transcription and surface expression. This study suggests that the benefit of steroids in nephritis stems from preventing lymphocyte infiltration into the kidney and decreasing immune interactions by limiting Ia expression.

This article has been cited by other articles:

				D. A. Mitchell, M. C. Pickering, J. Warren, L. Fossati-Jimack, J. Cortes-Hernandez, H. T. Cook, M. Botto, and M. J. Walport C1q Deficiency and Autoimmunity: The Effects of Genetic Background on Disease Expression J. Immunol., March 1, 2002; 168(5): 2538 - 2543. [Abstract] [Full Text] [PDF]

				D. A. Mitchell, P. R. Taylor, H. T. Cook, J. Moss, A. E. Bygrave, M. J. Walport, and M. Botto Cutting Edge: C1q Protects Against the Development of Glomerulonephritis Independently of C3 Activation J. Immunol., May 15, 1999; 162(10): 5676 - 5679. [Abstract] [Full Text] [PDF]

				M. B. Hogarth, J. H. Slingsby, P. J. Allen, E. M. Thompson, P. Chandler, K. A. Davies, E. Simpson, B. J. Morley, and M. J. Walport Multiple Lupus Susceptibility Loci Map to Chromosome 1 in BXSB Mice J. Immunol., September 15, 1998; 161(6): 2753 - 2761. [Abstract] [Full Text] [PDF]